Additionally, OSR1 expression correlates significantly with hormone receptor status, molecular subtypes, and histopathological classifications in patients with breast cancer, underscoring its relevance to clinicopathological heterogeneity and reinforcing its potential as a clinically significant molecular target. This evidence concerns the gene NR4A1 and breast carcinoma.